Friday, November 13, 2009
GSK donating 50 million H1N1 vaccine doses to the WHO
GSK (GlaxoSmithKline) is donating 50 million doses of H1N1 vaccine to the WHO (World Health Organization). These vaccines will be sent to developing countries that lack significant medical resources.
Here in the United States, we readily have access to antiviral medications and modern hospital facilities. That's not the case in most developing nations. As a result, the H1N1 pandemic may result in significant higher mortality in these countries. I'm glad to see pharmaceutical companies donating and contributing to global public health issues like this current H1N1 pandemic.